<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: Bax and Bak are regarded as key mediators for <z:chebi fb="1" ids="18070">cytochrome c</z:chebi> (<z:chebi fb="0" ids="16040">Cyt</z:chebi> c) release and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>Loss of Bax or Bak is often reported in human <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> and renders resistance of these cancerous cells to chemotherapy </plain></SENT>
<SENT sid="2" pm="."><plain>Here, we investigated that phenylarsine <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> (<z:chebi fb="1" ids="53240">PAO</z:chebi>) could induce Bax/Bak-independent <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="3" pm="."><plain>EXPERIMENTAL DESIGN: Annexin V/<z:chebi fb="0" ids="51240">propidium iodide</z:chebi> (PI) staining, terminal deoxynucleotidyl transferase-mediated <z:chebi fb="0" ids="17625">dUTP</z:chebi> nick end labeling (TUNEL) staining, and caspase activation assays were conducted to detect <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in Bax/Bak-deficient mouse embryonic fibroblasts (MEF) and HCT116 bax(-/-) <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="0" ids="16040">Cyt</z:chebi> c release and <z:chebi fb="3" ids="33173">Bim</z:chebi> expression were assessed by Western blotting and immunostaining </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="3" ids="33173">Bim</z:chebi> was stably knocked down by short hairpin <z:chebi fb="40" ids="33697">RNA</z:chebi> </plain></SENT>
<SENT sid="6" pm="."><plain>Immunoprecipitation was applied to detect the interaction between <z:chebi fb="3" ids="33173">Bim</z:chebi> and Bcl-2 </plain></SENT>
<SENT sid="7" pm="."><plain>Both subcutaneous and colorectal orthotopic <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> implantation models were used in <z:mp ids='MP_0003815'>nude</z:mp> mice to investigate the effect of <z:chebi fb="1" ids="53240">PAO</z:chebi> in vivo </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: <z:chebi fb="1" ids="53240">PAO</z:chebi> triggered <z:chebi fb="0" ids="16040">Cyt</z:chebi> c release and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in a Bax/Bak-independent manner </plain></SENT>
<SENT sid="9" pm="."><plain><z:chebi fb="3" ids="33173">Bim</z:chebi> and Bcl-2 were both involved in this process </plain></SENT>
<SENT sid="10" pm="."><plain><z:chebi fb="1" ids="53240">PAO</z:chebi> augmented the expression of <z:chebi fb="3" ids="33173">Bim</z:chebi> and strengthened the interaction between <z:chebi fb="3" ids="33173">Bim</z:chebi> and Bcl-2 </plain></SENT>
<SENT sid="11" pm="."><plain>Furthermore, <z:chebi fb="1" ids="53240">PAO</z:chebi> attenuated the growth of Bax-deficient <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells in vivo </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSIONS: Our results showed that <z:chebi fb="1" ids="53240">PAO</z:chebi> induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in chemotherapy-resistant <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells, which suggests that <z:chebi fb="1" ids="53240">PAO</z:chebi> has the potential to serve as a chemotherapeutic agent for Bax- and Bak-deficient <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
</text></document>